African Permanent Secretaries to Take Centre Stage at 2027 Genetic Biocontrol Congress in Nairobi
High-level discussions will focus on policy and regulatory readiness, scientific capacity and regional cooperation as African leaders engage with emerging technologies for vector control.
The 3rd Global Congress on Genetic Biocontrol Technologies, scheduled for 15–18 March 2027 in Nairobi, Kenya, will feature a high-level leadership forum bringing together Permanent Secretaries and other senior government officials, regulators, scientists and institutional leaders from across Africa.
Organised by the African Genetic Biocontrol Consortium (AGBC), the four-day Congress will provide a platform for scientific exchange and policy discussions on emerging genetic biocontrol approaches for public health, agriculture and ecosystem protection.
High-level African leadership forum
A major highlight of the Congress will be the high-level segment titled “Reimagining Africa’s Health Future Through Genetic Biocontrol”, scheduled for Monday, 15 March 2027.
The forum will bring together senior policymakers and regulatory leaders to consider how African countries can strengthen their preparedness to evaluate emerging genetic biocontrol technologies, including approaches being investigated to control malaria and other vector-borne diseases.
The programme identifies high-level government participation from Burkina Faso, Djibouti, Ghana, Kenya, Mali, Nigeria, Senegal, South Africa, Tanzania and Uganda, alongside regional organisations including Africa CDC, AUDA-NEPAD, ECOWAS and EASTECO.
Among the opening speakers listed in the programme is Prof. Shaukat Abdulrazak, Kenya’s Principal Secretary for Science, Research and Innovation.
Dr Lauren Carrington of the World Health Organization is scheduled to deliver a presentation examining vector-borne disease trends, existing interventions and emerging biocontrol approaches.
Her presentation will address evidence on genetically modified mosquitoes, Wolbachia-based population replacement and sterile insect techniques, alongside questions of safety, governance and implementation.
Regional policy and regulatory readiness
A regional leadership roundtable will examine the policy, legal and institutional arrangements needed for the responsible research, evaluation and potential implementation of emerging biocontrol technologies.
Discussions will focus on strengthening national regulatory frameworks, improving coordination across African countries and identifying opportunities for integrating appropriate technologies into disease control strategies.
A separate regulatory session will bring together officials from health, biosafety, biotechnology and environmental agencies to consider science-based approaches to risk assessment, field trials, cross-border consultation and post-release monitoring.
The leadership discussions will continue on 16 March, when participants are scheduled to assess institutional and research capacity, financing, public engagement and regulatory preparedness.
A key anticipated outcome is a leadership communiqué and action matrix identifying priority actions, areas for cooperation and mechanisms for follow-up.
Scientific research, innovation and public engagement
Beyond the high-level policy discussions, the Congress will feature scientific presentations on gene-drive research, Wolbachia-based approaches, sterile insect techniques and mosquito-associated microorganisms with potential applications in disease control.
Sessions will also address biosafety, environmental risk assessment, community engagement and the development of African research and regulatory capacity.
A dedicated workshop will examine the responsible application of artificial intelligence in genetic biocontrol decision-making, while science communication sessions will explore public understanding, trust and engagement with emerging biotechnologies.
The Congress aims to connect scientific advances with African-led policy discussions, ensuring that decisions about emerging technologies are informed by evidence, appropriate regulatory oversight and public participation.
The 3rd Global Congress on Genetic Biocontrol Technologies will take place from 15–18 March 2027 at the Radisson Blu Hotel, Nairobi, Kenya. Registration is ongoing.
